clopidogrel and Ischemia

clopidogrel has been researched along with Ischemia in 116 studies

Research

Studies (116)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (2.59)	18.2507
2000's	28 (24.14)	29.6817
2010's	64 (55.17)	24.3611
2020's	21 (18.10)	2.80

Authors

Authors	Studies
Baumgartner, I; Berger, JS; Blomster, JI; Fowkes, FGR; Hiatt, WR; Jones, WS; Katona, BG; Mahaffey, KW; Mulder, H; Norgren, L; North, R; Patel, MR; Rockhold, FW	1
Marcaccio, CL; Moreira, CC; Patel, PB; Rastogi, V; Schermerhorn, ML; Siracuse, JJ; Stangenberg, L; Wang, S	1
Ahmed, S; Gul, S; Hamdard, MH; Hussain, A; Janjua, K; Khan, H; Shah, SU; Sheikh, FS; Siraj, S	1
Li, X; Lin, Y; Peng, W; Zhang, Y	1
Ben-Yehuda, O; Brodie, BR; Cox, DA; Duffy, PL; Henry, TD; Kirtane, AJ; Liu, M; Madhavan, MV; Mazzaferri, EL; Mehran, R; Metzger, DC; Neumann, FJ; Redfors, B; Rinaldi, MJ; Shahim, B; Srdanovic, I; Stone, GW; Stuckey, TD; Weisz, G; Witzenbichler, B; Zhou, Z	1
Bae, JW; Bong, JM; Chun, KJ; Han, JK; Hwang, D; Kang, HJ; Kang, J; Kim, HS; Kim, SY; Koo, BK; Lee, BK; Lee, KS; Lee, NH; Lim, HS; Lim, YH; Park, K; Park, KH; Park, KW; Rha, SW; Rhew, JY; Shin, WY; Yang, HM	1
Aradi, D; Gross, L; Hadamitzky, M; Hein-Rothweiler, R; Komócsi, A; Massberg, S; Merkely, B; Rizas, KD; Sibbing, D; Trenk, D	1
Mantri, N; McNulty, E; Mutyala, R; Sachdeva, A; Solomon, M; Zhu, S	1
Alfredsson, J; Erlinge, D; James, S; Jernberg, T; Lindahl, B; Mohammad, MA; Omerovic, E; Szummer, K; Tjerkaski, J; Venetsanos, D	1
Goto, H; Kitahara, H; Kobayashi, Y; Matsumoto, T; Saito, Y; Sano, K; Sato, T; Suzuki, S; Wakabayashi, S; Yamashita, D	1
An, L; Hau, WK; Lei, M; Li, Y; Nie, S; Wang, J; Wang, X; Xue, Z; Yang, Y; Zhao, Z; Zhou, H	1
Han, Y; Li, J; Li, P; Li, Y; Liu, H; Na, K; Qi, Z; Qiu, M; Wang, B; Xu, K; Zhou, H	1
Ahn, JM; Cha, SJ; Jang, MH; Kang, DY; Kim, AR; Kim, JH; Kim, S; Kim, T; Kim, TO; Lee, J; Lee, JH; Lee, PH; Lee, YJ; Oh, HJ; Park, DW; Park, SJ	1
Cheng, N; Chiang, F; Hwang, J; Jimmy Juang, J; Lee, J; Lin, J; Lin, L; Tai, H; Tsai, C; Wu, C	1
Armstrong, DG; Caro, J; Clavijo, LC; Dhillon, AS; Rowe, V; Shavelle, DM; Tun, H	1
Hayashi, K; Honma, M; Iinuma, S; Ishida-Yamamoto, A; Kanno, K; Kinouchi, M; Nagasawa, Y; Obata, M; Sasaki, K; Sugawara, M	1
Abu-Assi, E; Alexopoulos, D; Ariza-Solé, A; Autelli, M; Biolè, C; Biondi-Zoccai, G; Blanco, PF; Boccuzzi, G; Bongiovanni, F; Cequier, A; Cerrato, E; Conrotto, F; Correia, L; D'Ascenzo, F; De Ferrari, GM; Dominguez-Rodriguez, A; Durante, A; Fabrizio, U; Fernández, MC; Fujii, T; Gaido, F; Gallo, D; Garay, A; Gili, S; González-Juanatey, JR; Grosso, A; Henriques, JPS; Huczek, Z; Iñiguez-Romo, A; Kawaji, T; Kawashiri, MA; Kinnaird, T; Liebetrau, C; Magnani, G; Manzano-Fernández, S; Montabone, A; Morbiducci, U; Nie, SP; Nuñez-Gil, I; Omedè, P; Paz, RC; Pousa, IM; Quadri, G; Queija, BC; Raposeiras-Roubin, S; Rettegno, S; Rognoni, A; Song, X; Stone, GW; Taha, S; Templin, C; Valdés, M; Velicki, L; Wilton, SB; Xanthopoulou, I	1
Agati, LB; Bernardi, WH; Biagioni, RB; Caffaro, RA; Casella, IB; Comerota, AJ; de Freitas Soares, BL; Fidelis, RJR; Fioranelli, A; Flumignan, RLG; Joviliano, EE; Junior, VC; Lopes, RD; Ramacciotti, E; Sacilotto, R; Sobreira, ML; Van Bellen, B; Wolosker, N	1
Baumgartner, I; Berger, JS; Blomster, JI; Fowkes, FGR; Gutierrez, JA; Heizer, GM; Held, P; Hiatt, WR; Jones, WS; Katona, BG; Mahaffey, KW; Norgren, L; Patel, MR; Rockhold, FW	1
Bikdeli, B; Cho, J; Gupta, A; Hripcsak, G; Kim, J; Krumholz, HM; Londhe, A; Madigan, D; Park, J; Park, RW; Reich, CG; Rho, Y; Ryan, PB; Schuemie, M; Siapos, A; Suchard, MA; Weaver, J; You, SC	1
Avram, R; Bailey, K; Byrne, J; Farkouh, ME; Geller, N; Goodman, SG; Iturriaga, E; Lennon, RJ; Marcus, GM; Murthy, V; Olgin, JE; Pereira, NL; Pletcher, MJ; Rihal, C; Rosenberg, Y; So, DY	1
Backhaus, R; Béchir, M; Burden, AM; Englberger, L; Hatz, KD; Ludin, K; Niedrig, D; Rahmany, A; Russmann, S; Serra, A	1
Bi, Q; Fu, P; Guo, F; Qiao, M; Song, Z; Wang, Y	1
Alexopoulos, D; Davlouros, P; Deftereos, S; Goudevenos, J; Hamilos, M; Kanakakis, I; Lekakis, J; Sitafidis, G; Vavouranakis, M; Xanthopoulou, I	1
Elmaraghi, S; Rinker, BD; Wilson, RM	1
Chao, TH; Chen, JY; Cheng, CL; Kao Yang, YH; Lee, CH; Li, YH	1
Jia, PP; Liu, H; Wang, GQ; Xie, YM; Zhang, Y; Zhuang, Y	1
Al-Asady, N; Caro, J; Clavijo, LC; Dhillon, A; Matthews, RV; Rowe, V; Shavelle, DM; Tun, H	1
Baumgartner, I; Berger, JS; Björck, M; Blomster, JI; Fowkes, FGR; Held, P; Hiatt, WR; Jones, WS; Katona, BG; Mahaffey, KW; Norgren, L; Patel, MR; Rockhold, FW; Wojdyla, DM	1
Bonello, L; Camoin-Jau, L; Gaubert, M; Laine, M; Paganelli, F; Resseguier, N	1
Appleton, JP; Bath, PM; Beridze, M; Christensen, H; Dineen, RA; Duley, L; England, TJ; Flaherty, K; Havard, D; Heptinstall, S; James, M; Krishnan, K; Markus, HS; Montgomery, AA; Pocock, SJ; Randall, M; Ranta, A; Robinson, TG; Scutt, P; Sprigg, N; Venables, GS; Woodhouse, LJ	1
Boland, P; Bourke, M; Chan, V; Chong, AY; Dupuis, JY; Goubran, D; Hibbert, B; James, TE; Lordkipanidzé, M; Malhotra, N; Perrault, L; Rubens, F; Ruel, M; Russo, JJ; Singh, K; So, DY; Tanguay, JF; Tran, DT; Wells, GA	1
Ardissino, D; Becker, RC; Cairns, R; Cannon, CP; Himmelmann, A; James, SK; Katus, HA; Mahaffey, KW; Storey, RF; Vignali, L; Wallentin, L	1
Barsan, W; Conwit, RA; Easton, JD; Elm, JJ; Farrant, M; Johnston, SC; Kim, AS; Lindblad, AS; Palesch, YY	1
Alderson, P; Lewis, SR; Pritchard, MW; Schofield-Robinson, OJ; Smith, AF	1
Apostolovic, S; Konstantinovic, SS; Lilic, J; Nikolic, VN; Pavlovic, M; Stokanovic, D; Zvezdanovic, JB	1
Baumgartner, I; Berger, JS; Blomster, J; Fowkes, FGR; Held, P; Hiatt, WR; Jones, WS; Katona, BG; Mahaffey, KW; Mulder, H; Norgren, L; Olivier, CB; Patel, MR; Rockhold, FW	1
Ensminger, SM; Heim, C; Khan, MA; Kuckhahn, A; Nicolls, MR; Ramsperger-Gleixner, M; Stamminger, T; von Silva-Tarouca, B; Weyand, M	1
Cao, X; Chen, X; Hu, W; Li, J; Liu, Z; Sun, Y; Xin, Y; Zhao, Y	1
Abad-Santos, F; Bárcena, E; Belmonte, C; Caniego, JL; Eugene, AR; Koller, D; Ochoa, D; Romero-Palacián, D; Saiz-Rodríguez, M; Zubiaur, P	1
Bode, C; Cornel, JH; Gibson, CM; James, S; Montalescot, G; Mundl, H; Nicolau, JC; Ohman, EM; Plotnikov, AN; Povsic, TJ; Rockhold, FW; Roe, MT; Steg, PG; Welsh, RC; White, J	1
Aradi, D; Dézsi, CA; Geisler, T; Gross, L; Hadamitzky, M; Holdt, L; Huber, K; Huczek, Z; Kiss, RG; Koltowski, L; Komócsi, A; Massberg, S; May, AE; Merkely, B; Mügge, A; Neumann, FJ; Rizas, KD; Ruzsa, Z; Sibbing, D; Trenk, D; Ungi, I; Zeiher, AM	1
Albers, GW; Barsan, WG; Cucchiara, BL; Easton, JD; Elm, JJ; Farrant, M; Johnston, SC; Kim, AS; Kleindorfer, DO; Lindblad, AS; Lutsep, HL; Palesch, YY; Pearson, C; Sethi, P; Vora, N; Zurita, KG	1
Aleil, B; Chakfe, N; Geny, B; Kretz, JG; Lejay, A; Stephan, D; Thaveau, F	1
Feng, Y; Guo, M; Li, H; Liang, G; Luo, X; Zhang, C; Zhang, F	1
Bennett, D; Yan, B	1
Jilma, B; Siller-Matula, JM	1
Bohn, RL; Choudhry, NK; Daniel, GW; Gagne, JJ; Liu, J; Patrick, AR; Rassen, JA; Schneeweiss, S; Sridhar, G	1
Chai, HT; Chang, HW; Chen, CH; Chen, YC; Chen, YL; Chua, S; Chung, SY; Ko, SF; Leu, S; Lin, PY; Sheu, JJ; Sung, PH; Tsai, TH; Yip, HK	1
Spiliopoulos, S	1
Cafaro, G; de Gaetano, G; Di Minno, A; Di Minno, G; Lupoli, R; Petitto, M; Spadarella, G; Tremoli, E	1
Alosh, M; Huque, MF; Koch, GG	1
Kelm, M; Merx, MW; Polzin, A; Scharf, RE; Schleicher, M; Seidel, H; Zeus, T	1
Baecker, C; Baro, D; Meybohm, P; Mutlak, H; Schmitz-Rixen, T; Wand, S; Weber, CF; Zacharowski, K	1
Cong, YL; Dong, M; Li, J; Sun, B; Wu, C; Yang, L; Zhu, L	1
Amsterdam, EA; Anderson, DR; Armstrong, EJ; Bang, H; Freischlag, JA; Laird, JR; Singh, GD; Yeo, KK	1
Afzal, S; Balzer, J; Kelm, M; Polzin, A; Rassaf, T; Zeus, T	1
Cheng, W; Chi, L; Lin, J; Wang, C; Wang, Y; Yi, X; Zhou, Q	1
Ansel, GM; Dake, MD; Jaff, MR; Machan, LS; O'Leary, EE; Ohki, T; Ragheb, AO; Saxon, RR; Smouse, HB; Snyder, SA; Zeller, T	1
Li, X; Ma, N; Mei, S; Miao, Z; Peng, S; Sun, S; Zhao, M; Zhao, Z	1
Fichter, AM; Mitchell, DA; Mücke, T; Ritschl, LM; Robitzky, LK; Wagenpfeil, S; Wolff, KD	1
Baumgartner, I; Berger, JS; Blomster, J; Fowkes, FG; Heizer, G; Held, P; Hiatt, WR; Jones, WS; Katona, BG; Mahaffey, KW; Millegård, M; Norgren, L; Patel, MR; Reist, C	1
Granath, F; Malmstedt, J; Thott, O; Wahlgren, CM	1
Hohlfeld, T; Zimmermann, N	1
Gurbel, PA; Tantry, US	2
Price, MJ	1
Mohler, ER	1
Angiolillo, DJ; Suryadevara, S	1
Angel, C; Beyssen, B; Bourquelot, P; Carreres, T; Hermelin, A; Novelli, L; Raynaud, A; Rovani, X	1
Collet, JP; Montalescot, G	1
Bertrand, ME; Cox, DA; Dangas, GD; Fahy, M; Feit, F; Kirtane, AJ; Lansky, AJ; Lincoff, AM; Manoukian, SV; McLaurin, B; Mehran, R; Moses, JW; Nikolsky, E; Ohman, EM; Stone, GW; White, HD	1
Dedaj, R; Levy, W	1
Lindhoff-Last, E; Tacke, J	1
Fareed, J; Jeske, WP; Mousa, SA	1
Adams, HP	1
Burdess, A; Dawson, AR; Fox, KA; Garden, OJ; Murie, JA; Newby, DE; Nimmo, AF	1
Bouman, HJ; Breet, NJ; Hackeng, CM; Kelder, JC; Ten Berg, JM; VAN Werkum, JW	1
Hwang, JY; Hwang, SJ; Jeong, YH; Kang, MK; Kim, IS; Kim, S; Koh, EH; Koh, JS; Kwak, CH; Park, JR; Park, KS; Park, Y	1
Abularrage, CJ; Cambria, RP; Conrad, MF; Crawford, RS; Hackney, LA; Lamuraglia, GM; Paruchuri, V; Patel, VI	1
Hayashi, K; Hiu, T; Kawakubo, J; Kitagawa, N; Morikawa, M; Morofuji, Y; Nagata, I; So, G; Suyama, K	1
Castriota, F; De Luca, G; De Servi, S; Kozinski, M; Kubica, J; Navarese, EP; Schaffer, A; Suriano, P; Verdoia, M	1
Bae, HJ; Cho, YJ; Han, MK; Hong, KS; Jeong, SW; Kang, DW; Kim, DE; Kim, GM; Kim, HY; Kim, JS; Koo, JS; Kwon, SU; Lee, BC; Lee, JH; Lee, KB; Lee, SH; Lee, YS; Mok, VC; Nah, HW; Park, JM; Rha, JH; Suwanwela, NC; Wong, KS; Yu, KH; Yun, SC	1
Aw, D; Sharma, JC	1
Endres, HG; Krogias, C; Meves, SH; Neubauer, H; Overbeck, U	1
Berger, PB; Bhakta, N; Bhatt, DL; Cacoub, P; Creager, MA; Eikelboom, JW; Emison, ES; Flather, MD; Fox, KA; Hacke, W; Kottke-Marchant, K; Lincoff, AM; Mak, KH; Mehta, SR; Montalescot, G; Murugesan, G; Paré, G; Simonsen, KL; Steg, PG; Steinhubl, SR; Topol, EJ	1
Ghosn, S; Sheikh-Taha, M	1
Chang, HW; Chen, YL; Chua, S; Leu, S; Lin, KC; Sheu, JJ; Sun, CK; Tsai, CY; Tsai, TH; Yang, JL; Yen, CH; Yip, HK	1
Meade, T	1
Guo, Q; Lu, Z; Sun, M; Zou, R	1
Buszman, PE; Buszman, PP; Kiesz, RS; Konkolewska, MD; Martin, JL; Radvany, MG; Szymanski, R; Wiernek, BK; Wiernek, SL	1
Chatterjee, S; Frankel, R; Ghose, A; Guha, G; Mukherjee, D; Sharma, A	1
Adams, JE; Ashikaga, T; Bertges, DJ; Dauerman, HL; Donaldson, CW; Elgharib, NZ; Mueller, EL; Prabhu, W; Schneider, DJ	1
Avegliano, G; Elorz, C; Evangelista, A; García del Castillo, H; González-Alujas, T; Soler-Soler, J	1
Rao, U; Weston, C	1
Clagett, GP; Jackson, MR; Lip, GY; Sobel, M; Tangelder, M; Verhaeghe, R	1
Griffin, S; Hawkins, N; Henderson, R; Jones, L; Main, C; Orton, V; Palmer, S; Riemsma, R; Sculpher, M; Sudlow, C	1
Akbas, MH; Berki, KT; Bulbul, S; Kanko, M; Maral, H; Omay, O; Ozden, M; Yavuz, S	1
Ben-Hur, T; Cohen, JE; Gomori, JM; Rajz, G; Umansky, F	1
Amighi, J; Brunner, M; Exner, M; Felber, K; Funk, M; Mannhalter, C; Minar, E; Mlekusch, W; Müller, M; Sabeti, S; Schillinger, M; Ziegler, S	1
Damkier, P; Hallas, J; Korsholm, L; Kristensen, SR; Mickley, H; Poulsen, TS; Vinholt, P	1
Berger, PB; Bhatt, DL; Black, HR; Boden, WE; Booth, J; Cacoub, P; Cohen, EA; Creager, MA; Easton, JD; Flather, MD; Fox, KA; Hacke, W; Haffner, SM; Hamm, CW; Hankey, GJ; Johnston, SC; Mak, KH; Mas, JL; Montalescot, G; Pearson, TA; Steg, PG; Steinhubl, SR; Topol, EJ; Weber, MA	1
Barnett, HJ; Norris, JW	1
Brittenden, J; Collins, P; Ford, I; Greaves, M; Macaulay, E	1
Haghfelt, TH; Heeg, B; Hout, Bv; Olsen, J; van Gestel, A	1
Hong, JT; Lee, SW; Son, BC; Sung, JH	1
Alessi, MC; Bonnet, JL; Camoin, L; Carvajal, J; Cuisset, T; Frere, C; Juhan-Vague, I; Lambert, M; Morange, PE; Quilici, J	1
Bhatt, DL	1
Ellahham, S	1
Andreozzi, GM; Arosio, E; Martini, R; Verlato, F; Visonà, A	1
Hermosillo, AJ; Spinler, SA	1
Born, GV; Collins, R	1
Dippel, DW	1
D'Sa, S; Machin, SJ	1
Bhatt, DL; Hacke, W; Hirsch, AT; Ringleb, PA; Topol, EJ	1
Bhatt, DL; Chew, DP; Hacke, W; Hirsch, AT; Ringleb, PA; Topol, EJ	1

Reviews

23 review(s) available for clopidogrel and Ischemia

Article	Year
Continuation versus discontinuation of antiplatelet therapy for bleeding and ischaemic events in adults undergoing non-cardiac surgery. The Cochrane database of systematic reviews, 2018, 07-18, Volume: 7 Topics: Adult; Aspirin; Cause of Death; Clopidogrel; Elective Surgical Procedures; Hemorrhage; Humans; Ischemia; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Ticlopidine; Withholding Treatment	2018
Suboptimal response to clopidogrel: a genetic risk factor for recurrent ischaemic stroke. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2013, Volume: 20, Issue:6 Topics: Aryl Hydrocarbon Hydroxylases; Clopidogrel; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Genotype; Humans; Ischemia; Pharmacogenetics; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Secondary Prevention; Stroke; Ticlopidine	2013
Antiplatelet therapy in critical limb ischemia: update on clopidogrel and cilostazol. The Journal of cardiovascular surgery, 2014, Volume: 55, Issue:5 Topics: Cilostazol; Clopidogrel; Combined Modality Therapy; Critical Illness; Drug Therapy, Combination; Endovascular Procedures; Humans; Ischemia; Lower Extremity; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Risk Factors; Stents; Tetrazoles; Ticlopidine; Treatment Outcome	2014
Systematic reviews and meta-analyses for more profitable strategies in peripheral artery disease. Annals of medicine, 2014, Volume: 46, Issue:7 Topics: Adenosine; Aspirin; Asymptomatic Diseases; Cilostazol; Clopidogrel; Fibrinolytic Agents; Humans; Intermittent Claudication; Ischemia; Lower Extremity; Meta-Analysis as Topic; Myocardial Infarction; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Primary Prevention; Review Literature as Topic; Secondary Prevention; Stroke; Tetrazoles; Thrombosis; Ticagrelor; Ticlopidine	2014
Clinical implications of aspirin resistance. Thrombosis and haemostasis, 2008, Volume: 100, Issue:3 Topics: Aspirin; Atherosclerosis; Clinical Trials as Topic; Clopidogrel; Coronary Disease; Drug Resistance; Humans; Ischemia; Research Design; Stroke; Thrombosis; Ticlopidine; Treatment Outcome	2008
The rationale for and comparisons of different antiplatelet treatments in acute coronary syndrome. Journal of interventional cardiology, 2008, Volume: 21 Suppl 1 Topics: Acute Coronary Syndrome; Aspirin; Blood Coagulation; Blood Platelets; Clopidogrel; Drug Therapy, Combination; Eptifibatide; Humans; Ischemia; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Risk Factors; Ticlopidine; Treatment Outcome	2008
Monitoring platelet function to reduce the risk of ischemic and bleeding complications. The American journal of cardiology, 2009, Feb-02, Volume: 103, Issue:3 Suppl Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Aspirin; Blood Platelets; Clopidogrel; Hemorrhage; Humans; Ischemia; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Risk Factors; Sensitivity and Specificity; Ticlopidine; Treatment Outcome	2009
Combination antiplatelet therapy in patients with peripheral arterial disease: is the best therapy aspirin, clopidogrel, or both? Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2009, Jul-01, Volume: 74 Suppl 1 Topics: Aspirin; Atherosclerosis; Clopidogrel; Drug Resistance; Drug Therapy, Combination; Evidence-Based Medicine; Hemodynamics; Hemorrhage; Humans; Ischemia; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Risk Assessment; Thrombosis; Ticlopidine; Treatment Outcome	2009
Aspirin and clopidogrel: efficacy and resistance in diabetes mellitus. Best practice & research. Clinical endocrinology & metabolism, 2009, Volume: 23, Issue:3 Topics: Aspirin; Clopidogrel; Diabetes Mellitus; Drug Resistance; Endothelium, Vascular; Humans; Ischemia; Oxidative Stress; Platelet Aggregation Inhibitors; Thrombosis; Ticlopidine	2009
Platelet function testing and implications for clinical practice. Journal of cardiovascular pharmacology and therapeutics, 2009, Volume: 14, Issue:3 Topics: Aspirin; Blood Platelets; Clopidogrel; Drug Resistance; Hemorrhage; Hemostasis; Humans; Ischemia; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Predictive Value of Tests; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Risk Assessment; Thrombosis; Ticlopidine; Treatment Outcome	2009
[Medicinal therapy for interventional surgery of the peripheral vascular system]. Der Radiologe, 2010, Volume: 50, Issue:1 Topics: Administration, Oral; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Drug Therapy, Combination; Heparin; Humans; Infusions, Intravenous; Ischemia; Leg; Long-Term Care; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Secondary Prevention; Thrombocytopenia; Thrombosis; Ticlopidine; Vitamin K	2010
Antiplatelet therapy prasugrel: a novel platelet ADP P2Y12 receptor antagonist. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2010, Volume: 16, Issue:2 Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Aspirin; Clinical Trials, Phase III as Topic; Clopidogrel; Drug Evaluation, Preclinical; Drug Therapy, Combination; Hemorrhage; Humans; Ischemia; Kidney Failure, Chronic; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2 Receptor Antagonists; Randomized Controlled Trials as Topic; Receptors, Purinergic P2Y12; Thiophenes; Ticlopidine	2010
Ischaemic and bleeding complications with new, compared to standard, ADP-antagonist regimens in acute coronary syndromes: a meta-analysis of randomized trials. QJM : monthly journal of the Association of Physicians, 2011, Volume: 104, Issue:7 Topics: Acute Coronary Syndrome; Adenosine; Administration, Oral; Clopidogrel; Hemorrhage; Humans; Ischemia; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Randomized Controlled Trials as Topic; Thiophenes; Ticagrelor; Ticlopidine	2011
Antiplatelets in secondary stroke prevention: should clopidogrel be the first choice? Postgraduate medical journal, 2012, Volume: 88, Issue:1035 Topics: Aspirin; Clopidogrel; Dipyridamole; Humans; Ischemia; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Ticlopidine; Treatment Outcome	2012
Primary prevention of ischaemic cardiovascular disorders with antiplatelet agents. Handbook of experimental pharmacology, 2012, Issue:210 Topics: Aspirin; Cardiovascular Diseases; Clinical Trials as Topic; Clopidogrel; Humans; Ischemia; Myocardial Infarction; Platelet Aggregation Inhibitors; Stroke; Thrombosis; Ticlopidine	2012
Comparing newer oral anti-platelets prasugrel and ticagrelor in reduction of ischemic events-evidence from a network meta-analysis. Journal of thrombosis and thrombolysis, 2013, Volume: 36, Issue:3 Topics: Adenosine; Clopidogrel; Hemorrhage; Humans; Ischemia; Piperazines; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Prasugrel Hydrochloride; PubMed; Randomized Controlled Trials as Topic; Stents; Thiophenes; Thrombosis; Ticagrelor; Ticlopidine	2013
Antiplatelet drug resistance and variability in response: the role of antiplatelet therapy monitoring. Current pharmaceutical design, 2013, Volume: 19, Issue:21 Topics: Aspirin; Clopidogrel; Coronary Artery Disease; Cost Savings; Drug Monitoring; Drug Resistance; Drug Substitution; Drug Therapy, Combination; Humans; Ischemia; Platelet Aggregation Inhibitors; Secondary Prevention; Thrombosis; Ticlopidine	2013
Antiplatelet agents in atherothrombotic diseases. Hospital medicine (London, England : 1998), 2004, Volume: 65, Issue:2 Topics: Arteriosclerosis; Aspirin; Clopidogrel; Dipyridamole; Humans; Ischemia; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Ticlopidine	2004
Antithrombotic therapy in peripheral arterial occlusive disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 2004, Volume: 126, Issue:3 Suppl Topics: Arterial Occlusive Diseases; Aspirin; Cilostazol; Clopidogrel; Contraindications; Evidence-Based Medicine; Extremities; Fibrinolytic Agents; Heparin; Humans; Intermittent Claudication; Ischemia; Randomized Controlled Trials as Topic; Risk Assessment; Tetrazoles; Thromboembolism; Ticlopidine; Vitamin K	2004
Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation. Health technology assessment (Winchester, England), 2004, Volume: 8, Issue:38 Topics: Aspirin; Clopidogrel; Cost-Benefit Analysis; Delayed-Action Preparations; Diarrhea; Dipyridamole; Drug Costs; Drug Eruptions; Dyspepsia; Evidence-Based Medicine; Hemorrhage; Humans; Ischemia; Models, Econometric; Nausea; Platelet Aggregation Inhibitors; Research Design; Risk Factors; Ticlopidine; Treatment Outcome; Vascular Diseases; Vomiting	2004
Role of antiplatelet agents in the primary and secondary prevention of atherothrombotic events in high risk-patients. Southern medical journal, 2008, Volume: 101, Issue:3 Topics: Aspirin; Atherosclerosis; Clinical Trials as Topic; Clopidogrel; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Ischemia; Platelet Aggregation Inhibitors; Practice Patterns, Physicians'; Thrombosis; Ticlopidine	2008
Aspirin, clopidogrel, and warfarin: is the combination appropriate and effective or inappropriate and too dangerous? The Annals of pharmacotherapy, 2008, Volume: 42, Issue:6 Topics: Anticoagulants; Aspirin; Clinical Trials as Topic; Clopidogrel; Drug Interactions; Drug Therapy, Combination; Hemorrhage; Humans; Ischemia; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Ticlopidine; Vascular Diseases; Warfarin	2008
The results of CAPRIE, IST and CAST. Clopidogrel vs. Aspirin in Patients at Risk of Ischaemic Events. International Stroke Trial. Chinese Acute Stroke Trial. Thrombosis research, 1998, Sep-15, Volume: 92, Issue:1 Suppl 1 Topics: Aspirin; Cerebrovascular Disorders; Clopidogrel; Double-Blind Method; Humans; Ischemia; Myocardial Infarction; Platelet Aggregation Inhibitors; Recurrence; Ticlopidine	1998

Trials

28 trial(s) available for clopidogrel and Ischemia

Article	Year
World regional differences in outcomes for patients with peripheral artery disease: Insights from the EUCLID trial. Vascular medicine (London, England), 2022, Volume: 27, Issue:1 Topics: Clopidogrel; Humans; Internationality; Ischemia; Ischemic Stroke; Myocardial Infarction; Peripheral Arterial Disease; Ticagrelor; Treatment Outcome	2022
Prasugrel dose de-escalation in diabetic patients with acute coronary syndrome receiving percutaneous coronary intervention: results from the HOST-REDUCE-POLYTECH-ACS trial. European heart journal. Cardiovascular pharmacotherapy, 2023, 04-10, Volume: 9, Issue:3 Topics: Acute Coronary Syndrome; Brain Ischemia; Clopidogrel; Diabetes Mellitus; Hemorrhage; Humans; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Stroke	2023
Impact of body mass on P2Y12-inhibitor de-escalation in acute coronary syndromes-a substudy of the TROPICAL-ACS trial. European heart journal. Cardiovascular pharmacotherapy, 2023, 11-02, Volume: 9, Issue:7 Topics: Acute Coronary Syndrome; Clopidogrel; Hemorrhage; Humans; Ischemia; Overweight; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride	2023
Rationale and design for the study Apixaban versus ClopidoGRel on a background of aspirin in patient undergoing InfraPoPliteal angioplasty for critical limb ischemia: AGRIPPA trial. American heart journal, 2020, Volume: 227 Topics: Angioplasty; Aspirin; Clopidogrel; Critical Illness; Factor Xa Inhibitors; Humans; Ischemia; Leg; Multicenter Studies as Topic; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Popliteal Artery; Postoperative Complications; Proof of Concept Study; Prospective Studies; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Thrombosis	2020
CYP2C19 status and risk of major adverse cardiovascular events in peripheral artery disease: Insights from the EUCLID Trial. American heart journal, 2020, Volume: 229 Topics: Cardiovascular Diseases; Clopidogrel; Cytochrome P-450 CYP2C19; Extremities; Female; Hemorrhage; Humans; Ischemia; Loss of Function Mutation; Male; Middle Aged; Outcome and Process Assessment, Health Care; Peripheral Arterial Disease; Pharmacogenomic Testing; Platelet Aggregation Inhibitors; Vascular Surgical Procedures	2020
Outcomes of Patients with Critical Limb Ischaemia in the EUCLID Trial. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2018, Volume: 55, Issue:1 Topics: Adenosine; Aged; Clopidogrel; Female; Hospitalization; Humans; Hypertension; Incidence; Ischemia; Kaplan-Meier Estimate; Limb Salvage; Lower Extremity; Male; Middle Aged; Peripheral Arterial Disease; Proportional Hazards Models; Prospective Studies; Purinergic P2Y Receptor Antagonists; Risk Factors; Stroke; Ticagrelor; Ticlopidine; Treatment Outcome; Vascular Surgical Procedures	2018
Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial. Lancet (London, England), 2018, 03-03, Volume: 391, Issue:10123 Topics: Acute Disease; Aged; Aspirin; Brain Ischemia; Clopidogrel; Denmark; Dipyridamole; Drug Therapy, Combination; Female; Georgia; Hemorrhage; Humans; Ischemia; Ischemic Attack, Transient; Male; Middle Aged; New Zealand; Platelet Aggregation Inhibitors; Prospective Studies; Recurrence; Research Design; Risk Assessment; Stroke; Thrombolytic Therapy; Ticlopidine; Treatment Outcome; United Kingdom	2018
Ischaemic Events and Stent Thrombosis following Planned Discontinuation of Study Treatment with Ticagrelor or Clopidogrel in the PLATO Study. Thrombosis and haemostasis, 2018, Volume: 118, Issue:2 Topics: Aged; Blood Platelets; Clopidogrel; Female; Humans; Ischemia; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Stents; Thrombosis; Ticagrelor; Time Factors; Treatment Outcome	2018
Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA. The New England journal of medicine, 2018, Jul-19, Volume: 379, Issue:3 Topics: Aged; Aspirin; Brain Ischemia; Clopidogrel; Double-Blind Method; Drug Therapy, Combination; Female; Hemorrhage; Humans; Ischemia; Ischemic Attack, Transient; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Risk; Secondary Prevention; Stroke; Ticlopidine	2018
Incidence, Characteristics, and Outcomes of Myocardial Infarction in Patients With Peripheral Artery Disease: Insights From the EUCLID Trial. JAMA cardiology, 2019, 01-01, Volume: 4, Issue:1 Topics: Aged; Ankle Brachial Index; Clopidogrel; Coronary Artery Bypass; Death; Extremities; Female; Hospitalization; Humans; Incidence; Ischemia; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Risk Factors; Ticagrelor	2019
P2Y12 Inhibitor Switching in Response to Routine Notification of CYP2C19 Clopidogrel Metabolizer Status Following Acute Coronary Syndromes. JAMA cardiology, 2019, 07-01, Volume: 4, Issue:7 Topics: Acute Coronary Syndrome; Aspirin; Clopidogrel; Cytochrome P-450 CYP2C19; Drug Administration Schedule; Drug Substitution; Drug Therapy, Combination; Hemorrhage; Humans; Ischemia; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Rivaroxaban; Ticagrelor	2019
Platelet reactivity and clinical outcomes in acute coronary syndrome patients treated with prasugrel and clopidogrel: a pre-specified exploratory analysis from the TROPICAL-ACS trial. European heart journal, 2019, 06-21, Volume: 40, Issue:24 Topics: Acute Coronary Syndrome; Aged; Blood Platelets; Case-Control Studies; Clopidogrel; Death; Drug Therapy, Combination; Female; Hemorrhage; Humans; Ischemia; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Function Tests; Prasugrel Hydrochloride; Risk Assessment; Stroke; Treatment Outcome	2019
Time Course for Benefit and Risk of Clopidogrel and Aspirin After Acute Transient Ischemic Attack and Minor Ischemic Stroke. Circulation, 2019, 08-20, Volume: 140, Issue:8 Topics: Acute Disease; Aspirin; Clinical Protocols; Clopidogrel; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Hemorrhage; Humans; Ischemia; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Proportional Hazards Models; Risk; Risk Assessment; Stroke; Time Factors	2019
A prospective randomized controlled clinical trial on clopidogrel combined with warfarin versus clopidogrel alone in the prevention of restenosis after endovascular treatment of the femoropopliteal artery. Annals of vascular surgery, 2013, Volume: 27, Issue:5 Topics: Aged; Anticoagulants; Clopidogrel; Constriction, Pathologic; Drug Therapy, Combination; Endovascular Procedures; Female; Femoral Artery; Humans; Ischemia; Male; Perioperative Care; Platelet Aggregation Inhibitors; Popliteal Artery; Recurrence; Ticlopidine; Warfarin	2013
Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial. Circulation, 2016, Apr-12, Volume: 133, Issue:15 Topics: Adult; Aged; Angioplasty; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Combined Modality Therapy; Disease Progression; Disease-Free Survival; Drug-Eluting Stents; Equipment Failure; Female; Femoral Artery; Follow-Up Studies; Humans; Intermittent Claudication; Ischemia; Male; Middle Aged; Paclitaxel; Popliteal Artery; Recurrence; Stents; Ticlopidine; Vascular Patency	2016
Impact of genetic polymorphisms related to clopidogrel or acetylsalicylic acid pharmacology on clinical outcome in Chinese patients with symptomatic extracranial or intracranial stenosis. European journal of clinical pharmacology, 2016, Volume: 72, Issue:10 Topics: Aged; Asian People; Aspirin; Carboxylic Ester Hydrolases; Clopidogrel; Constriction, Pathologic; Cytochrome P-450 CYP2C19; Female; Genotype; Humans; Ischemia; Male; Middle Aged; Mutation; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide; Ticlopidine; Treatment Outcome	2016
Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease. The New England journal of medicine, 2017, 01-05, Volume: 376, Issue:1 Topics: Adenosine; Aged; Cardiovascular Diseases; Clopidogrel; Double-Blind Method; Female; Hemorrhage; Humans; Intermittent Claudication; Ischemia; Kaplan-Meier Estimate; Leg; Male; Middle Aged; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Ticagrelor; Ticlopidine	2017
Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. Journal of the American College of Cardiology, 2009, Sep-29, Volume: 54, Issue:14 Topics: Acute Coronary Syndrome; Age Factors; Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Clopidogrel; Coronary Artery Bypass; Female; Gastrointestinal Hemorrhage; Heparin; Hirudins; Humans; Incidence; Ischemia; Length of Stay; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Peptide Fragments; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Recombinant Proteins; Risk Assessment; Sex Factors; Stents; Thrombosis; Ticlopidine	2009
Ticagrelor, a new antiplatelet agent, for prevention of ischemic events in patients with coronary artery disease. Current neurology and neuroscience reports, 2010, Volume: 10, Issue:1 Topics: Adenosine; Clopidogrel; Coronary Artery Disease; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Ischemia; Male; Platelet Aggregation Inhibitors; Proportional Hazards Models; Ticagrelor; Ticlopidine; Time Factors; Treatment Outcome	2010
Randomized controlled trial of dual antiplatelet therapy in patients undergoing surgery for critical limb ischemia. Annals of surgery, 2010, Volume: 252, Issue:1 Topics: Aged; Amputation, Surgical; Aspirin; Clopidogrel; Double-Blind Method; Female; Flow Cytometry; Hemorrhage; Humans; Ischemia; Leg; Male; Myocardial Infarction; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticlopidine; Troponin	2010
Cytochrome 2C19 polymorphism and response to adjunctive cilostazol versus high maintenance-dose clopidogrel in patients undergoing percutaneous coronary intervention. Circulation. Cardiovascular interventions, 2010, Volume: 3, Issue:5 Topics: Adenosine Diphosphate; Angioplasty, Balloon, Coronary; Aryl Hydrocarbon Hydroxylases; Blood Platelets; Chemotherapy, Adjuvant; Cilostazol; Clopidogrel; Codon, Nonsense; Cytochrome P-450 CYP2C19; DNA Mutational Analysis; Humans; Ischemia; Platelet Aggregation; Polymorphism, Genetic; Receptors, Purinergic P2Y12; Tetrazoles; Ticlopidine	2010
Efficacy and safety of combination antiplatelet therapies in patients with symptomatic intracranial atherosclerotic stenosis. Stroke, 2011, Volume: 42, Issue:10 Topics: Aged; Aged, 80 and over; Cilostazol; Clopidogrel; Constriction, Pathologic; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Intracranial Arteriosclerosis; Ischemia; Male; Middle Aged; Platelet Aggregation Inhibitors; Tetrazoles; Ticlopidine; Treatment Outcome	2011
The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics study. European heart journal, 2012, Volume: 33, Issue:17 Topics: Aryl Hydrocarbon Hydroxylases; Atherosclerosis; Clopidogrel; Cytochrome P-450 CYP2C19; Female; Genotype; Hemorrhage; Heterozygote; Humans; Ischemia; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Stroke; Thrombosis; Ticlopidine	2012
Increased local cytokine production at culprit superficial femoral artery plaques. Journal of thrombosis and thrombolysis, 2013, Volume: 36, Issue:3 Topics: Aspirin; CD40 Ligand; Clopidogrel; Constriction, Pathologic; Female; Femoral Artery; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemia; Lower Extremity; Lymphotoxin-alpha; Male; Middle Aged; Plaque, Atherosclerotic; Platelet Aggregation Inhibitors; Prospective Studies; Ticlopidine	2013
A global view of atherothrombosis: baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial. American heart journal, 2005, Volume: 150, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Brain Ischemia; Cardiovascular Diseases; Clopidogrel; Coronary Disease; Female; Humans; Ischemia; Leg; Male; Middle Aged; Myocardial Infarction; Risk Factors; Ticlopidine	2005
The results of CAPRIE, IST and CAST. Clopidogrel vs. Aspirin in Patients at Risk of Ischaemic Events. International Stroke Trial. Chinese Acute Stroke Trial. Thrombosis research, 1998, Sep-15, Volume: 92, Issue:1 Suppl 1 Topics: Aspirin; Cerebrovascular Disorders; Clopidogrel; Double-Blind Method; Humans; Ischemia; Myocardial Infarction; Platelet Aggregation Inhibitors; Recurrence; Ticlopidine	1998
Reduction in the need for hospitalization for recurrent ischemic events and bleeding with clopidogrel instead of aspirin. CAPRIE investigators. American heart journal, 2000, Volume: 140, Issue:1 Topics: Aspirin; Brain Ischemia; Cause of Death; Clopidogrel; Confidence Intervals; Double-Blind Method; Female; Hemorrhage; Hospitalization; Humans; Incidence; Ischemia; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Probability; Prognosis; Proportional Hazards Models; Risk Assessment; Secondary Prevention; Survival Analysis; Ticlopidine	2000
Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery. Circulation, 2001, Jan-23, Volume: 103, Issue:3 Topics: Aspirin; Cardiac Surgical Procedures; Clopidogrel; Double-Blind Method; Female; Hospitalization; Humans; Ischemia; Male; Middle Aged; Multivariate Analysis; Platelet Aggregation Inhibitors; Postoperative Complications; Risk Factors; Ticlopidine	2001

Other Studies

66 other study(ies) available for clopidogrel and Ischemia

Article	Year
Effect of postoperative antithrombotic therapy on lower extremity outcomes after infrapopliteal bypass for chronic limb-threatening ischemia. Journal of vascular surgery, 2022, Volume: 75, Issue:5 Topics: Aged; Anticoagulants; Aspirin; Chronic Limb-Threatening Ischemia; Clopidogrel; Fibrinolytic Agents; Humans; Ischemia; Lower Extremity; Medicare; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Risk Factors; Treatment Outcome; United States	2022
Antiplatelet response to clopidogrel is associated with a haplotype in CYP2C19 gene in Pakistani patients. Scientific reports, 2022, 04-13, Volume: 12, Issue:1 Topics: Clopidogrel; Cytochrome P-450 CYP2C19; Genotype; Haplotypes; Humans; Ischemia; Pakistan; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome	2022
Efficacy and Safety of Clopidogrel Versus Ticagrelor for Stabilized Patients With Acute Coronary Syndromes After Percutaneous Coronary Intervention: Results From a Real-World Registry in China. Journal of cardiovascular pharmacology, 2023, 02-01, Volume: 81, Issue:2 Topics: Acute Coronary Syndrome; Aspirin; Clopidogrel; Hemorrhage; Humans; Ischemia; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Registries; Ticagrelor; Treatment Outcome	2023
On-Treatment Platelet Reactivity and Ischemic Outcomes in Patients With Diabetes Mellitus: Two-Year Results From ADAPT-DES. Journal of the American Heart Association, 2023, 01-03, Volume: 12, Issue:1 Topics: Blood Platelets; Clopidogrel; Coronary Artery Disease; Diabetes Mellitus; Humans; Ischemia; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prospective Studies; Risk Factors; Treatment Outcome	2023
P2Y12 Inhibitors in Acute Coronary Syndromes: A Real-World, Community-Based Comparison of Ischemic and Bleeding Outcomes. Journal of interventional cardiology, 2023, Volume: 2023 Topics: Acute Coronary Syndrome; Clopidogrel; Hemorrhage; Humans; Ischemia; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Retrospective Studies; Ticagrelor; Treatment Outcome	2023
Comparison between ticagrelor and clopidogrel in myocardial infarction patients with high bleeding risk. European heart journal. Cardiovascular pharmacotherapy, 2023, 11-02, Volume: 9, Issue:7 Topics: Clopidogrel; Hemorrhage; Humans; Ischemia; Myocardial Infarction; Platelet Aggregation Inhibitors; Stroke; Ticagrelor	2023
Differential Impact of Clinical Factors for Predicting High Platelet Reactivity on Clinical Outcomes in Acute Myocardial Infarction Patients Treated With Clopidogrel and Prasugrel. Journal of atherosclerosis and thrombosis, 2023, Dec-01, Volume: 30, Issue:12 Topics: Acute Coronary Syndrome; Aged; Clopidogrel; Diabetes Mellitus; Humans; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Treatment Outcome	2023
A novel de-escalation antiplatelet therapy for patients with acute coronary syndrome undergoing percutaneous coronary intervention. Medicine, 2023, Jul-07, Volume: 102, Issue:27 Topics: Acute Coronary Syndrome; Aspirin; Clopidogrel; Hemorrhage; Humans; Ischemia; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Ticagrelor; Treatment Outcome	2023
Contemporary Use of Ticagrelor vs Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A GRACE Risk Score Stratification-Based Analysis in a Large-Scale, Real-World Study From China. Mayo Clinic proceedings, 2023, Volume: 98, Issue:7 Topics: Acute Coronary Syndrome; China; Clopidogrel; Hemorrhage; Humans; Ischemia; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Registries; Risk Assessment; Risk Factors; Ticagrelor; Treatment Outcome	2023
Age- and Sex-Specific Disparities in Outcomes After Ticagrelor Versus Clopidogrel in East Asian Patients. The American journal of cardiology, 2023, 11-15, Volume: 207 Topics: Acute Coronary Syndrome; Aged; Clopidogrel; East Asian People; Female; Hemorrhage; Humans; Ischemia; Male; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Ticagrelor; Treatment Outcome	2023
CYP2C19 Polymorphism is Associated With Amputation Rates in Patients Taking Clopidogrel After Endovascular Intervention for Critical Limb Ischaemia. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2019, Volume: 58, Issue:3 Topics: Aged; Aged, 80 and over; Amputation, Surgical; Clopidogrel; Cytochrome P-450 CYP2C19; DNA; Endovascular Procedures; Female; Humans; Ischemia; Lower Extremity; Male; Polymorphism, Genetic; Postoperative Period; Prognosis; Purinergic P2Y Receptor Antagonists; Reoperation; Retrospective Studies	2019
Therapeutic Window of Clopidogrel and Ticagrelor in Patients With Critical Limb-Threatening Ischemia. Journal of cardiovascular pharmacology and therapeutics, 2020, Volume: 25, Issue:2 Topics: Aged; Clopidogrel; Critical Illness; Drug Administration Schedule; Drug Monitoring; Female; Humans; Ischemia; Male; Middle Aged; Peripheral Arterial Disease; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Purinergic P2Y Receptor Antagonists; Ticagrelor; Time Factors; Treatment Outcome	2020
Cutaneous thrombosis associated with eltrombopag treatment for immune thrombocytopenia. The Journal of dermatology, 2020, Volume: 47, Issue:2 Topics: Aged; Benzoates; Biopsy; Clopidogrel; Computed Tomography Angiography; Conservative Treatment; Female; Humans; Hydrazines; Hyperbaric Oxygenation; Ischemia; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Skin; Thrombosis; Tibial Arteries; Toes; Treatment Outcome; Warfarin	2020
Average daily ischemic versus bleeding risk in patients with ACS undergoing PCI: Insights from the BleeMACS and RENAMI registries. American heart journal, 2020, Volume: 220 Topics: Acute Coronary Syndrome; Aged; Clopidogrel; Female; Hemorrhage; Humans; Ischemia; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Prasugrel Hydrochloride; Recurrence; Registries; ST Elevation Myocardial Infarction; Ticagrelor; Time Factors	2020
Association of Ticagrelor vs Clopidogrel With Net Adverse Clinical Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. JAMA, 2020, 10-27, Volume: 324, Issue:16 Topics: Acute Coronary Syndrome; Adult; Aged; Aged, 80 and over; Algorithms; Aspirin; Case-Control Studies; Cause of Death; Clopidogrel; Databases, Factual; Dyspnea; Female; Hemorrhage; Humans; Ischemia; Male; Middle Aged; Myocardial Infarction; Network Meta-Analysis; Percutaneous Coronary Intervention; Propensity Score; Purinergic P2Y Receptor Antagonists; Recurrence; Republic of Korea; Retrospective Studies; Stroke; Ticagrelor; United States	2020
Rationale and design of the TAILOR-PCI digital study: Transitioning a randomized controlled trial to a digital registry. American heart journal, 2021, Volume: 232 Topics: Clopidogrel; Continuity of Patient Care; COVID-19; Feasibility Studies; Follow-Up Studies; Genotype; Geographic Information Systems; Health Surveys; Humans; Internet-Based Intervention; Ischemia; Mobile Applications; Multicenter Studies as Topic; Patient Compliance; Patient Generated Health Data; Patient Participation; Percutaneous Coronary Intervention; Postoperative Complications; Pragmatic Clinical Trials as Topic; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Registries; Research Design; SARS-CoV-2; Telephone	2021
Implementation and management outcomes of pharmacogenetic CYP2C19 testing for clopidogrel therapy in clinical practice. European journal of clinical pharmacology, 2021, Volume: 77, Issue:5 Topics: Aged; Aged, 80 and over; Case-Control Studies; Clopidogrel; Cytochrome P-450 CYP2C19; Female; Genotype; Heart Disease Risk Factors; Humans; Ischemia; Male; Middle Aged; Pharmacogenomic Testing; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide; Precision Medicine; Prospective Studies; Recurrence	2021
Previous hypertensive hemorrhage increases the risk for bleeding and ischemia for PCI patients on dual antiplatelet therapy. Neurological research, 2017, Volume: 39, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Aspirin; Case-Control Studies; Clopidogrel; Drug Therapy, Combination; Female; Hemorrhage; Humans; Ischemia; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Ticlopidine	2017
Gender-related differences in antiplatelet treatment patterns and outcome: Insights from the GReekAntiPlatElet Registry. Cardiovascular therapeutics, 2017, Volume: 35, Issue:4 Topics: Acute Coronary Syndrome; Aged; Cardiovascular Diseases; Clopidogrel; Cohort Studies; Female; Greece; Hemorrhage; Humans; Ischemia; Male; Middle Aged; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Prospective Studies; Registries; Risk Factors; Sex Characteristics; Stents; Ticlopidine; Treatment Outcome	2017
Ischemic Hand Complications From Intra-Arterial Injection of Sublingual Buprenorphine/Naloxone Among Patients With Opioid Dependency. Hand (New York, N.Y.), 2017, Volume: 12, Issue:5 Topics: Adult; Aspirin; Buprenorphine, Naloxone Drug Combination; Clopidogrel; Female; Fibrinolytic Agents; Hand; Heparin; Humans; Injections, Intra-Arterial; Ischemia; Male; Middle Aged; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Platelet Aggregation Inhibitors; Retrospective Studies; Young Adult	2017
Cardiovascular and Bleeding Risks in Acute Myocardial Infarction Newly Treated With Ticagrelor vs. Clopidogrel in Taiwan. Circulation journal : official journal of the Japanese Circulation Society, 2018, 02-23, Volume: 82, Issue:3 Topics: Aged; Asian People; Cardiovascular Diseases; Clopidogrel; Hemorrhage; Humans; Ischemia; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Propensity Score; Purinergic P2Y Receptor Antagonists; Retrospective Studies; Risk; Taiwan; Ticagrelor; Treatment Outcome	2018
[Drug combination characteristics of Shenxiong glucose injection in treating ischemic cerebrovascular disease in real world]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2017, Volume: 42, Issue:14 Topics: Aspirin; Atorvastatin; Cerebrovascular Disorders; China; Clopidogrel; Drug Therapy, Combination; Drugs, Chinese Herbal; Ginkgo biloba; Hospital Information Systems; Humans; Ischemia; Medicine, Chinese Traditional; Plant Extracts	2017
Prevalence of high on-treatment (aspirin and clopidogrel) platelet reactivity in patients with critical limb ischemia. Cardiovascular revascularization medicine : including molecular interventions, 2018, Volume: 19, Issue:5 Pt A Topics: Aged; Aged, 80 and over; Aspirin; Blood Platelets; Cell Adhesion Molecules; Clopidogrel; Critical Illness; Drug Therapy, Combination; Female; Humans; Ischemia; Male; Microfilament Proteins; Middle Aged; Peripheral Arterial Disease; Phosphoproteins; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Thromboxane A2; Time Factors; Treatment Outcome	2018
Dabigatran versus vitamin k antagonist: an observational across-cohort comparison in acute coronary syndrome patients with atrial fibrillation. Journal of thrombosis and haemostasis : JTH, 2018, Volume: 16, Issue:3 Topics: Acute Coronary Syndrome; Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Blood Platelets; Clopidogrel; Cohort Studies; Coronary Angiography; Dabigatran; Female; Glomerular Filtration Rate; Hemorrhage; Humans; Incidence; Ischemia; Kaplan-Meier Estimate; Male; Middle Aged; Outcome Assessment, Health Care; Patient Safety; Phenindione; Propensity Score; Proportional Hazards Models; Risk; Treatment Outcome; Vitamin K	2018
Ischemic and bleeding outcomes after coronary artery bypass grafting among patients initially treated with a P2Y European heart journal. Acute cardiovascular care, 2019, Volume: 8, Issue:6 Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Case-Control Studies; Clopidogrel; Coronary Angiography; Coronary Artery Bypass; Female; Humans; Ischemia; Male; Middle Aged; Myocardial Infarction; Postoperative Hemorrhage; Prospective Studies; Purinergic P2Y Receptor Antagonists; Stroke; Ticagrelor; Time Factors; Treatment Outcome; Withholding Treatment	2019
The association between clopidogrel and 2-oxo-clopidogrel plasma levels and the long-term clinical outcome after acute myocardial infarction . International journal of clinical pharmacology and therapeutics, 2019, Volume: 57, Issue:2 Topics: Clopidogrel; Humans; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome	2019
Preservation of Microvascular Integrity in Murine Orthotopic Tracheal Allografts by Clopidogrel. Transplantation, 2019, Volume: 103, Issue:5 Topics: Allografts; Animals; Clopidogrel; Disease Models, Animal; Graft Rejection; Humans; Injections, Intraperitoneal; Ischemia; Lung Transplantation; Mice; Microvessels; Platelet Aggregation Inhibitors; Trachea; Transplantation, Homologous; Treatment Outcome	2019
Derivation and Evaluation of the Ischemic Risk Model in High-Risk Chinese Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome. Clinical therapeutics, 2019, Volume: 41, Issue:4 Topics: Acute Coronary Syndrome; Aged; China; Clopidogrel; Female; Humans; Ischemia; Male; Middle Aged; Models, Biological; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prognosis; Risk; Ticagrelor	2019
Influence of CYP450 Enzymes, CES1, PON1, ABCB1, and P2RY12 Polymorphisms on Clopidogrel Response in Patients Subjected to a Percutaneous Neurointervention. Clinical therapeutics, 2019, Volume: 41, Issue:6 Topics: Aged; Aryldialkylphosphatase; ATP Binding Cassette Transporter, Subfamily B; Carboxylic Ester Hydrolases; Cerebrovascular Disorders; Clopidogrel; Cytochrome P-450 Enzyme System; Female; Hemorrhage; Humans; Ischemia; Male; Middle Aged; Platelet Aggregation Inhibitors; Receptors, Purinergic P2Y12; Retrospective Studies	2019
Platelet antiaggregation therapy and subinguinal endovascular revascularization. Annals of vascular surgery, 2013, Volume: 27, Issue:5 Topics: Aged; Aged, 80 and over; Clopidogrel; Endovascular Procedures; Humans; Ischemia; Lower Extremity; Medication Adherence; Middle Aged; Platelet Aggregation Inhibitors; Ticlopidine	2013
Why have studies of tailored anti-platelet therapy failed so far? Thrombosis and haemostasis, 2013, Volume: 110, Issue:4 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Diseases; Clopidogrel; Drug Resistance; Humans; Ischemia; Platelet Activation; Platelet Aggregation Inhibitors; Precision Medicine; Randomized Controlled Trials as Topic; Research Design; Ticlopidine; Treatment Failure	2013
Near-real-time monitoring of new drugs: an application comparing prasugrel versus clopidogrel. Drug safety, 2014, Volume: 37, Issue:3 Topics: Aged; Clopidogrel; Cohort Studies; Databases, Factual; Electronic Health Records; Female; Hemorrhage; Humans; Ischemia; Male; Middle Aged; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Product Surveillance, Postmarketing; Purinergic P2Y Receptor Antagonists; Thiophenes; Ticlopidine	2014
Levels and values of lipoprotein-associated phospholipase A2, galectin-3, RhoA/ROCK, and endothelial progenitor cells in critical limb ischemia: pharmaco-therapeutic role of cilostazol and clopidogrel combination therapy. Journal of translational medicine, 2014, Apr-17, Volume: 12 Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Aged; Base Sequence; Cilostazol; Clopidogrel; DNA Primers; Drug Therapy, Combination; Endothelial Progenitor Cells; Extremities; Female; Galectin 3; Humans; Ischemia; Male; Platelet Aggregation Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; rho-Associated Kinases; Tetrazoles; Ticlopidine	2014
Statistical Perspectives on Subgroup Analysis: Testing for Heterogeneity and Evaluating Error Rate for the Complementary Subgroup. Journal of biopharmaceutical statistics, 2015, Volume: 25, Issue:6 Topics: Algorithms; Antibiotics, Antineoplastic; Antineoplastic Agents; Aspirin; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Clopidogrel; Doxorubicin; Female; Humans; Ischemia; Ovarian Neoplasms; Platelet Aggregation Inhibitors; Reproducibility of Results; Research Design; Sample Size; Ticlopidine; Topotecan	2015
High on-treatment platelet reactivity in transcatheter aortic valve implantation patients. European journal of pharmacology, 2015, Mar-15, Volume: 751 Topics: Aged; Aspirin; Blood Platelets; Clopidogrel; Female; Humans; Ischemia; Male; Platelet Aggregation Inhibitors; Ticlopidine; Transcatheter Aortic Valve Replacement	2015
Response to dual antiplatelet therapy in patients with peripheral artery occlusive disease suffering from critical limb ischemia. Clinical laboratory, 2014, Volume: 60, Issue:10 Topics: Aged; Aged, 80 and over; Area Under Curve; Aspirin; Clopidogrel; Critical Illness; Drug Resistance; Drug Therapy, Combination; Female; Germany; Humans; Ischemia; Male; Middle Aged; Peripheral Arterial Disease; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Prospective Studies; ROC Curve; Ticlopidine; Time Factors; Treatment Outcome	2014
Diversity of platelet function and genetic polymorphism in clopidogrel-treated Chinese patients. Genetics and molecular research : GMR, 2015, Feb-13, Volume: 14, Issue:1 Topics: Adenosine Diphosphate; Adult; Aged; Alleles; Blood Coagulation; Blood Platelets; China; Clopidogrel; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Female; Genotype; Humans; Ischemia; Logistic Models; Male; Middle Aged; Mutation; Percutaneous Coronary Intervention; Pharmacogenetics; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Precision Medicine; Receptors, Purinergic P2Y12; Recurrence; Thrombelastography; Ticlopidine	2015
Association of dual-antiplatelet therapy with reduced major adverse cardiovascular events in patients with symptomatic peripheral arterial disease. Journal of vascular surgery, 2015, Volume: 62, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Amputation, Surgical; Aspirin; California; Cardiovascular Diseases; Chi-Square Distribution; Clopidogrel; Critical Illness; Drug Therapy, Combination; Female; Humans; Intermittent Claudication; Ischemia; Kaplan-Meier Estimate; Male; Middle Aged; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Platelet Function Tests; Point-of-Care Systems; Predictive Value of Tests; Propensity Score; Proportional Hazards Models; Registries; Risk Factors; Ticlopidine; Time Factors; Treatment Outcome	2015
Platelet reactivity in MitraClip patients. Vascular pharmacology, 2016, Volume: 77 Topics: Aspirin; Clopidogrel; Cohort Studies; Heart Valve Prosthesis Implantation; Hemorrhage; Ischemia; Mitral Valve Insufficiency; Platelet Aggregation; Platelet Aggregation Inhibitors; Thrombosis; Ticlopidine	2016
Association of Cytochrome P450 Genetic Variants with Clopidogrel Resistance and Outcomes in Acute Ischemic Stroke. Journal of atherosclerosis and thrombosis, 2016, Oct-01, Volume: 23, Issue:10 Topics: Aged; Clopidogrel; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Female; Humans; Ischemia; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Function Tests; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Prospective Studies; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Stroke; Ticlopidine	2016
Impact of different antithrombotics on the microcirculation and viability of perforator-based ischaemic skin flaps in a small animal model. Scientific reports, 2016, 10-21, Volume: 6 Topics: Animals; Aspirin; Clopidogrel; Disease Models, Animal; Fibrinolytic Agents; Graft Survival; Heparin; Hirudins; Ischemia; Laser-Doppler Flowmetry; Male; Microcirculation; Pentoxifylline; Postoperative Complications; Rats; Rats, Wistar; Skin Diseases; Skin Transplantation; Surgical Flaps; Ticlopidine	2016
Editor's Choice - Dual Antiplatelet Therapy Improves Outcome in Diabetic Patients Undergoing Endovascular Femoropopliteal Stenting for Critical Limb Ischaemia. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2017, Volume: 53, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Amputation, Surgical; Aspirin; Clopidogrel; Constriction, Pathologic; Critical Illness; Diabetic Angiopathies; Drug Therapy, Combination; Endovascular Procedures; Female; Femoral Artery; Humans; Ischemia; Kaplan-Meier Estimate; Limb Salvage; Male; Middle Aged; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Popliteal Artery; Proportional Hazards Models; Registries; Retrospective Studies; Risk Factors; Stents; Sweden; Ticlopidine; Time Factors; Treatment Outcome	2017
Radiocephalic fistula complicated by distal ischemia: treatment by ulnar artery dilatation. Cardiovascular and interventional radiology, 2010, Volume: 33, Issue:1 Topics: Aged; Angioplasty, Balloon; Arterial Occlusive Diseases; Catheters, Indwelling; Clopidogrel; Diabetes Mellitus, Type 1; Enoxaparin; Female; Hand; Heparin; Humans; Insect Hormones; Ischemia; Peritoneal Dialysis; Ticlopidine; Ulnar Artery	2010
Aortic thromboembolism successfully treated with anticoagulation and antiplatelet therapy. The American journal of medicine, 2009, Volume: 122, Issue:12 Topics: Anticoagulants; Aorta, Thoracic; Arm; Clopidogrel; Coronary Artery Disease; Echocardiography, Transesophageal; Humans; Ischemia; Male; Middle Aged; Platelet Aggregation Inhibitors; Thromboembolism; Ticlopidine; Warfarin	2009
Do not adjust the platelet count in light transmittance aggregometry when predicting thrombotic events after percutaneous coronary intervention. Journal of thrombosis and haemostasis : JTH, 2010, Volume: 8, Issue:10 Topics: Angioplasty, Balloon, Coronary; Aspirin; Blood Platelets; Clopidogrel; Cohort Studies; Humans; Ischemia; Odds Ratio; Platelet Aggregation Inhibitors; Platelet Count; Prospective Studies; ROC Curve; Thrombosis; Ticlopidine	2010
Endovascular management of patients with critical limb ischemia. Journal of vascular surgery, 2011, Volume: 53, Issue:4 Topics: Aged; Aged, 80 and over; Amputation, Surgical; Angioplasty, Balloon; Boston; Clopidogrel; Critical Illness; Female; Humans; Ischemia; Kaplan-Meier Estimate; Limb Salvage; Lower Extremity; Male; Middle Aged; Patient Selection; Platelet Aggregation Inhibitors; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Risk Factors; Stents; Ticlopidine; Time Factors; Treatment Outcome; Vascular Patency	2011
[Preoperative analysis of platelet aggregability in carotid surgery]. No shinkei geka. Neurological surgery, 2011, Volume: 39, Issue:5 Topics: Aged; Aged, 80 and over; Aspirin; Carotid Arteries; Clopidogrel; Endarterectomy, Carotid; Female; Humans; Intraoperative Complications; Ischemia; Male; Middle Aged; Perioperative Period; Platelet Aggregation; Platelet Aggregation Inhibitors; Postoperative Complications; Retrospective Studies; Stents; Ticlopidine	2011
Dose-dependent effect of early antiplatelet therapy in acute ischaemic stroke. Thrombosis and haemostasis, 2012, Volume: 107, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Aspirin; Body Mass Index; Brain Ischemia; Clopidogrel; Dose-Response Relationship, Drug; Female; Humans; Ischemia; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Stroke; Ticlopidine	2012
Comparison of bolus only with bolus plus infusion of bivalirudin in patients undergoing elective percutaneous coronary intervention: a retrospective observational study. Journal of pharmacy practice, 2012, Volume: 25, Issue:5 Topics: Aged; Alabama; Antithrombins; Aspirin; Clopidogrel; Dose-Response Relationship, Drug; Elective Surgical Procedures; Female; Hemorrhage; Hirudins; Humans; Incidence; Infusions, Intravenous; Injections, Intravenous; Ischemia; Male; Middle Aged; Peptide Fragments; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Recombinant Proteins; Retrospective Studies; Severity of Illness Index; Thrombosis; Ticlopidine	2012
Combination of cilostazol and clopidogrel attenuates rat critical limb ischemia. Journal of translational medicine, 2012, Aug-16, Volume: 10 Topics: Animals; Blotting, Western; Cilostazol; Clopidogrel; Drug Therapy, Combination; Extremities; Flow Cytometry; Immunohistochemistry; Ischemia; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Tetrazoles; Ticlopidine	2012
Influence of ischemia before vein grafting on early hyperplasia of the graft and the dynamic changes of the intima after grafting. Journal of cardiothoracic surgery, 2012, Sep-24, Volume: 7 Topics: Animals; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Cell Proliferation; Clopidogrel; Endothelial Cells; Histocytochemistry; Hyperplasia; Ischemia; Ki-67 Antigen; Microscopy, Electron, Scanning; Platelet Aggregation Inhibitors; Rabbits; Ticlopidine; Tunica Intima	2012
Long-term results of plaque excision combined with aggressive pharmacotherapy in high-risk patients with advanced peripheral artery disease (SAVE a LEG registry). Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2013, Sep-01, Volume: 82, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Amputation, Surgical; Aspirin; Atherectomy; Atorvastatin; Cardiovascular Agents; Clopidogrel; Combined Modality Therapy; Critical Illness; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Intermittent Claudication; Ischemia; Kaplan-Meier Estimate; Limb Salvage; Male; Middle Aged; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Pyrroles; Recurrence; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Ticlopidine; Time Factors; Treatment Outcome	2013
Acute peripheral arterial ischemia and suspected aortic dissection: usefulness of transesophageal echocardiography in differential diagnosis with aortic thrombosis. The American journal of cardiology, 2002, Sep-15, Volume: 90, Issue:6 Topics: Acute Disease; Adult; Aged; Amputation, Surgical; Anticoagulants; Aortic Diseases; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Diagnosis, Differential; Echocardiography, Transesophageal; Female; Follow-Up Studies; Humans; Ischemia; Leg; Male; Middle Aged; Spain; Thrombectomy; Thrombosis; Ticlopidine; Tomography, X-Ray Computed; Treatment Outcome; Warfarin	2002
Protective effects of clopidogrel on oxidant damage in a rat model of acute ischemia. The Tohoku journal of experimental medicine, 2005, Volume: 205, Issue:2 Topics: Animals; Clopidogrel; Disease Models, Animal; Glutathione; Ischemia; Male; Malondialdehyde; Oxidants; Oxidative Stress; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Superoxide Dismutase; Ticlopidine	2005
Endovascular stent-assisted angioplasty in the management of traumatic internal carotid artery dissections. Stroke, 2005, Volume: 36, Issue:4 Topics: Adult; Angiography; Angioplasty; Anticoagulants; Aspirin; Blood Platelets; Blood Vessel Prosthesis Implantation; Carotid Arteries; Carotid Artery, Internal; Carotid Artery, Internal, Dissection; Clopidogrel; Constriction, Pathologic; Diffusion; Female; Humans; Ischemia; Male; Middle Aged; Perfusion; Prognosis; Stents; Stroke; Ticlopidine; Time Factors; Tomography, X-Ray Computed; Wounds and Injuries	2005
Association of a functional polymorphism in the clopidogrel target receptor gene, P2Y12, and the risk for ischemic cerebrovascular events in patients with peripheral artery disease. Stroke, 2005, Volume: 36, Issue:7 Topics: Aged; Alleles; Aspirin; Brain Ischemia; Cerebrovascular Circulation; Clopidogrel; Cohort Studies; Exons; Gene Frequency; Genetic Predisposition to Disease; Genotype; Heterozygote; Humans; Ischemia; Membrane Proteins; Middle Aged; Mutation; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Polymerase Chain Reaction; Polymorphism, Genetic; Prevalence; Proportional Hazards Models; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Stroke; Ticlopidine; Time Factors; Treatment Outcome	2005
The antiplatelet effect of clopidogrel is not attenuated by statin treatment in stable patients with ischemic heart disease. Thrombosis and haemostasis, 2005, Volume: 94, Issue:2 Topics: Aged; Atorvastatin; Blood Platelets; Cholesterol, LDL; Clopidogrel; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Female; Heart Diseases; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemia; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Pravastatin; Pyrroles; Simvastatin; Ticlopidine; Time Factors; Wound Healing	2005
CHARISMA: the antiplatelet saga continues. Stroke, 2006, Volume: 37, Issue:9 Topics: Atherosclerosis; Clinical Trials as Topic; Clopidogrel; Humans; Ischemia; Platelet Aggregation Inhibitors; Thrombosis; Ticlopidine; Treatment Failure	2006
Surgical revascularisation in patients with severe limb ischaemia induces a pro-thrombotic state. Platelets, 2006, Volume: 17, Issue:5 Topics: Aged; Aged, 80 and over; Antithrombin III; Arterial Occlusive Diseases; Aspirin; Blood Coagulation; Clopidogrel; Female; Fibrin Fibrinogen Degradation Products; Humans; Ischemia; Male; P-Selectin; Peptide Hydrolases; Platelet Aggregation; Platelet Aggregation Inhibitors; Postoperative Complications; Reperfusion; Thrombosis; Ticlopidine; Vascular Surgical Procedures; von Willebrand Factor	2006
[Cost-effectiveness of clopidogrel vs. aspirin treatment in high-risk acute coronary syndrome patients in Denmark]. Ugeskrift for laeger, 2006, Aug-28, Volume: 168, Issue:35 Topics: Acute Disease; Aged; Aspirin; Cardiovascular Diseases; Clopidogrel; Coronary Artery Bypass; Coronary Disease; Cost-Benefit Analysis; Humans; Ischemia; Leg; Middle Aged; Myocardial Ischemia; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Syndrome; Ticlopidine	2006
Clopidogrel-induced spontaneous spinal epidural hematoma. Journal of Korean medical science, 2007, Volume: 22, Issue:3 Topics: Aged; Brain; Cerebral Angiography; Clopidogrel; Female; Hematoma, Epidural, Spinal; Humans; Ischemia; Magnetic Resonance Imaging; Platelet Aggregation Inhibitors; Ticlopidine; Time Factors; Treatment Outcome	2007
ADP-induced platelet aggregation and platelet reactivity index VASP are good predictive markers for clinical outcomes in non-ST elevation acute coronary syndrome. Thrombosis and haemostasis, 2007, Volume: 98, Issue:4 Topics: Acute Coronary Syndrome; Acute Disease; Adenosine Diphosphate; Aged; Blood Platelets; Cell Adhesion Molecules; Clopidogrel; Female; Humans; Ischemia; Male; Microfilament Proteins; Middle Aged; Phosphoproteins; Phosphorylation; Platelet Aggregation; ROC Curve; Ticlopidine; Treatment Outcome	2007
Intensifying platelet inhibition--navigating between Scylla and Charybdis. The New England journal of medicine, 2007, Nov-15, Volume: 357, Issue:20 Topics: Acute Coronary Syndrome; Aspirin; Clopidogrel; Drug Therapy, Combination; Hemorrhage; Humans; Ischemia; Piperazines; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Thiophenes; Ticlopidine	2007
Consensus document on intermittent claudication from the Central European Vascular Forum 1st edition - Abano Terme (Italy) - May 2005 2nd revision - Portroz (Slovenia) September 2007. International angiology : a journal of the International Union of Angiology, 2008, Volume: 27, Issue:2 Topics: Aspirin; Carotid Stenosis; Clopidogrel; Disease Progression; Exercise Test; Humans; Intermittent Claudication; Ischemia; Leg; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Ticlopidine; Ultrasonography, Doppler, Color	2008
Aspirin versus clopidogrel: the wrong question? Lancet (London, England), 1997, Mar-15, Volume: 349, Issue:9054 Topics: Aspirin; Cerebrovascular Disorders; Clopidogrel; Humans; Ischemia; Myocardial Infarction; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Research Design; Ticlopidine; Treatment Outcome	1997
Clopidogrel: a novel antiplatelet agent. Hospital medicine (London, England : 1998), 1999, Volume: 60, Issue:5 Topics: Adenosine Diphosphate; Aspirin; Clopidogrel; Humans; Ischemia; Myocardial Infarction; Platelet Aggregation Inhibitors; Ticlopidine; Vascular Diseases	1999